Oct. 3 at 9:39 PM
$GANX Never going to happen and Gene and Khalid know it, they just can't say it. They likely know they will never even get the opportunity to do the phase 2. Have to position as if you will for leverage however, see how Khalid played Jazz Pharmaceuticals like a fiddle for
$1B, just months after they offered just half that. He is the ultimate poker player and darn good at it. Just ask all the funds that made a fortune betting on him.
Every large pharma name you would want at the table already has a place setting and some are surely pretty hungry one must assume. Some have been there for a a couple yeara now. That patent cliff is closing in and pipelines are empty, CNS is a hot spot.
A disease modifying drug for Parkinson’s is priceless, worth many many billions. It's ultimate value will undoubtedly be unlocked through either partnership, but more likely acquisition by large pharma.
My money remains on Merck, just like I once said about
$PRVB and Sanofi.
Stay the course...
